ArticleMethods in molecular biology (Clifton, N.J.)2025
A Rapid Yeast-Based System for Modifying Respiratory Syncytial Virus.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The addition of marker protein genes to respiratory syncytial virus (RSV) has enabled studies of the spread of RSV in different types of cell cultures and quantification of viral replication in those cultures. Genetic deletion of individual RSV genes from RSV genome has been used to determine their importance in virus infection and the differences between infection of cultured cells lines and of primary well-differentiated human bronchial epithelial (HBE) cultures. Modifications of individual viral proteins can identify the importance of a particular glycosylation, cleavage, or antigenic sites or reveal sites with these functions. However, the standard recombinant systems for the RSV genome, based on natural and inserted restriction sites, have been difficult to use, slow to accomplish, and frequently not successful. Here, we describe a yeast-based cDNA assembly system that streamlines both the construction of a cDNA clone of an RSV strain as well as any modification of an RSV cDNA, thereby enabling the rapid generation of an RSV mutant virus.
Indexed as
Identifiers
40879901What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.